Publication | Closed Access

Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results

Intermittent TreatmentPulmonary TuberculosisLate ResultsAntibioticsTuberculosis PreventionPharmacologyTuberculosisMedicineExperimental Murine TuberculosisDrug Resistance